Astellas Submits U.S. New Drug Application for Tacrolimus Extended Release ... Sacramento Bee Developed by Astellas, tacrolimus extended release capsules are a once daily formulation of calcineurin-inhibitor immunosuppressant tacrolimus. The NDA submission is based on six randomized and comparative studies of 2,842 (1,689 tacrolimus extended ... |
